Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 117 items for :

  • "hormone replacement therapy" x
Clear All
Renata C Scalco Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
Disciplina de Endocrinologia, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, São Paulo, Brazil
Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Renata C Scalco in
Google Scholar
PubMed Close
,
Ericka B Trarbach Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Ericka B Trarbach in
Google Scholar
PubMed Close
,
Edoarda V A Albuquerque Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Edoarda V A Albuquerque in
Google Scholar
PubMed Close
,
Thais K Homma Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Thais K Homma in
Google Scholar
PubMed Close
,
Thais H Inoue-Lima Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Thais H Inoue-Lima in
Google Scholar
PubMed Close
,
Mirian Y Nishi Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Mirian Y Nishi in
Google Scholar
PubMed Close
,
Berenice B Mendonca Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Berenice B Mendonca in
Google Scholar
PubMed Close
, and
Alexander A L Jorge Unidade de Endocrinologia Genetica, Laboratorio de Endocrinologia Celular e Molecular LIM/25, Disciplina de Endocrinologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil

Search for other papers by Alexander A L Jorge in
Google Scholar
PubMed Close

, affecting approximately 25–50 per 100,000 females. Hypergonadotropic hypogonadism is a frequent manifestation, present in more than 95% of TS patients. Therefore, most patients will need hormone replacement therapy (HRT) for puberty induction, attaining of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0398
Volume/Issue:
Volume 8: Issue 11
Open access
Nathalie Ly Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France

Search for other papers by Nathalie Ly in
Google Scholar
PubMed Close
,
Sophie Dubreuil Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France

Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed Close
, and
Philippe Touraine Department of Endocrinology and Reproductive Medicine, Reference Center for Rare Endocrine Diseases of Growth and Development, Reference Center for Gynecological Rare Diseases, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France

Search for other papers by Philippe Touraine in
Google Scholar
PubMed Close

Höybye C Carroll P Gordon MB Birkegård AC Kelepouris N Nedjatian N Weber MM . Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0241
Volume/Issue:
Volume 11: Issue 12
Open access
Jennifer K Y Ko Department of Women’s Health, University College London Hospital, London, UK

Search for other papers by Jennifer K Y Ko in
Google Scholar
PubMed Close
,
Thomas F J King Department of Women’s Health, University College London Hospital, London, UK

Search for other papers by Thomas F J King in
Google Scholar
PubMed Close
,
Louise Williams Department of Women’s Health, University College London Hospital, London, UK

Search for other papers by Louise Williams in
Google Scholar
PubMed Close
,
Sarah M Creighton Department of Women’s Health, University College London Hospital, London, UK

Search for other papers by Sarah M Creighton in
Google Scholar
PubMed Close
, and
Gerard S Conway Department of Women’s Health, University College London Hospital, London, UK

Search for other papers by Gerard S Conway in
Google Scholar
PubMed Close

after completion of puberty ( 2 ). Hormone replacement therapy (HRT) is required after gonadectomy in order to maintain secondary sexual characteristics, bone and cardiovascular health and to promote general wellbeing and sexual function. In the study by

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0083
Volume/Issue:
Volume 6: Issue 6
Open access
Kjersti S Bakken Women’s Clinic, Innlandet Hospital Trust, Lillehammer, Norway
Center for International Health, University of Bergen, Bergen, Norway

Search for other papers by Kjersti S Bakken in
Google Scholar
PubMed Close
,
Kristina Randjelovic Nermo Center for International Health, University of Bergen, Bergen, Norway
Department of Microbiology, Innlandet Hospital Trust, Lillehammer, Norway

Search for other papers by Kristina Randjelovic Nermo in
Google Scholar
PubMed Close
,
Bjørn Gunnar Nedrebø Department of Medicine, Haugesund Hospital, Haugesund, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Bjørn Gunnar Nedrebø in
Google Scholar
PubMed Close
,
Tim I M Korevaar Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands

Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed Close
, and
Tor A Strand Center for International Health, University of Bergen, Bergen, Norway
Department of Research, Innlandet Hospital Trust, Lillehammer, Norway

Search for other papers by Tor A Strand in
Google Scholar
PubMed Close

provided with two separate files which were combined using the pseudonymized patient identification numbers. Thyroid treatment was coded into three categories based on the ATC-codes: (i) thyroid hormone replacement therapy, which included women that had

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0631
Volume/Issue:
Volume 11: Issue 4
Open access
Carina Ankarberg-Lindgren Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Carina Ankarberg-Lindgren in
Google Scholar
PubMed Close
,
Aneta Gawlik Department of Pediatrics and Pediatric Endocrinology, Medical University of Silesia, School of Medicine, Katowice, Poland

Search for other papers by Aneta Gawlik in
Google Scholar
PubMed Close
,
Berit Kriström Department of Clinical Sciences/Pediatrics, Umeå University, Umeå, Sweden

Search for other papers by Berit Kriström in
Google Scholar
PubMed Close
,
Laura Mazzanti Pediatric Endocrinology and Rare Disease Unit, Department of Medical and Surgical Science, University of Bologna, Bologna, Italy

Search for other papers by Laura Mazzanti in
Google Scholar
PubMed Close
,
Elisabeth J Ruijgrok Department of Pharmacy, Erasmus Medical Center – Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands

Search for other papers by Elisabeth J Ruijgrok in
Google Scholar
PubMed Close
, and
Theo C J Sas Department of Pediatric Endocrinology, Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands
Diabeter, National Diabetes Care and Research Center, Rotterdam, the Netherlands

Search for other papers by Theo C J Sas in
Google Scholar
PubMed Close

Objective

Transdermal estradiol patches are primarily designed for adult women. No low-dose patches are licensed for pubertal induction in hypogonadal girls. Low doses can be achieved by cutting a matrix patch into smaller pieces. However, the manufacturers do not guarantee stability or utility of cut estradiol patches. The aim of the study was to assess 1-month stability of cut estradiol patches from four different manufacturers in the laboratory at room temperature (+21°C) and at an elevated temperature (+35°C).

Design and methods

Estraderm MX 50 µg, Systen 50 µg and Oesclim 25 µg matrix patches were cut into eight pieces while Estradot 50 µg small patches were cut in half. The cut patches were stored in their respective pouches at +21°C or at +35°C for up to 1 month. The estradiol drug was extracted from the patch by ethyl acetate n-hexane and determined by radioimmunoassay.

Results

Storage at +21°C or +35°C up to 1 month did not reduce the estradiol concentration in Estraderm MX, Systen and Oesclim patches. However, although the estradiol in Estradot patches was not affected by storage at +21°C, at +35°C, estradiol decreased by 57% (±1%) in cut pieces.

Conclusions

Unused Estraderm MX, Systen and Oesclim patch pieces may be stored for at least 1 month at ≤+35°C. Where estradiol patches for children are not available, cut pieces of these or similar patches can be used for pubertal induction. The Estradot patch was too small to properly cut into low doses and not stable in elevated temperatures.

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0025
Volume/Issue:
Volume 8: Issue 4
Open access
Trine Holm Johannsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed Close
,
Jakob Albrethsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jakob Albrethsen in
Google Scholar
PubMed Close
,
Vassos Neocleous The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Vassos Neocleous in
Google Scholar
PubMed Close
,
Federico Baronio S. Orsola-Malpighi University Hospital, Department of Medical and Surgical Sciences, Bologna, Italy

Search for other papers by Federico Baronio in
Google Scholar
PubMed Close
,
Martine Cools Department of Pediatrics, Division of Pediatric Endocrinology, Ghent University Hospital and Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

Search for other papers by Martine Cools in
Google Scholar
PubMed Close
,
Lise Aksglaede Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lise Aksglaede in
Google Scholar
PubMed Close
,
Niels Jørgensen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Niels Jørgensen in
Google Scholar
PubMed Close
,
Peter Christiansen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Peter Christiansen in
Google Scholar
PubMed Close
,
Meropi Toumba The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus
Pediatric Endocrinology Clinic, Department of Pediatrics, Aretaeio Hospital, Nicosia, Cyprus

Search for other papers by Meropi Toumba in
Google Scholar
PubMed Close
,
Pavlos Fanis The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Pavlos Fanis in
Google Scholar
PubMed Close
,
Marie Lindhardt Ljubicic Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Marie Lindhardt Ljubicic in
Google Scholar
PubMed Close
, and
Anders Juul Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close

calculated as weight (kg) divided by height (m) squared. Body surface area (BSA) was calculated according to the formula by the Du Bois method: BSA = 0.007184 × weight (kg) 0.425 × height (cm) 0.725 ( 11 ); and (iv) hormone replacement therapy: total dose

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0073
Volume/Issue:
Volume 12: Issue 8
Open access
Izabelle Lövgren Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed Close
,
Azadeh Abravan Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Azadeh Abravan in
Google Scholar
PubMed Close
,
Abigail Bryce-Atkinson Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed Close
, and
Marcel van Herk Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Marcel van Herk in
Google Scholar
PubMed Close

-term quality of life for the patients but also benefit the healthcare system financially by reducing the overall treatment costs, as life-long hormone replacement therapy may be avoided. This review aims to address the late effects of cranial RT on the

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0298
Volume/Issue:
Volume 11: Issue 12
Open access
Corina Verónica Sasso Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Corina Verónica Sasso in
Google Scholar
PubMed Close
,
Flavia Eliana Santiano Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina
Universidad de Mendoza, Mendoza, Argentina

Search for other papers by Flavia Eliana Santiano in
Google Scholar
PubMed Close
,
Fiorella Campo Verde Arboccó Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina
Universidad de Mendoza, Mendoza, Argentina

Search for other papers by Fiorella Campo Verde Arboccó in
Google Scholar
PubMed Close
,
Leila Ester Zyla Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Leila Ester Zyla in
Google Scholar
PubMed Close
,
Silvana Noemí Semino Hospital Universitario, Universidad Nacional de Cuyo, Mendoza, Argentina

Search for other papers by Silvana Noemí Semino in
Google Scholar
PubMed Close
,
Martin Eduardo Guerrero-Gimenez Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Martin Eduardo Guerrero-Gimenez in
Google Scholar
PubMed Close
,
Virginia Pistone Creydt Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Virginia Pistone Creydt in
Google Scholar
PubMed Close
,
Constanza Matilde López Fontana Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Constanza Matilde López Fontana in
Google Scholar
PubMed Close
, and
Rubén Walter Carón Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), CCT-Mendoza CONICET, Mendoza, Argentina

Search for other papers by Rubén Walter Carón in
Google Scholar
PubMed Close

with previous studies describing that the effects produced by P4 are opposite to those of E2 ( 18 ). In addition, there are also studies showing that estrogen-only hormone replacement therapy does not produce changes in the prevalence or survival after

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0374
Volume/Issue:
Volume 8: Issue 3
Open access
Emmanuelle Noirrit Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France

Search for other papers by Emmanuelle Noirrit in
Google Scholar
PubMed Close
,
Mélissa Buscato Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France

Search for other papers by Mélissa Buscato in
Google Scholar
PubMed Close
,
Marion Dupuis Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France

Search for other papers by Marion Dupuis in
Google Scholar
PubMed Close
,
Bernard Payrastre Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France
CHU de Toulouse, Laboratoire d’Hématologie, Toulouse, France

Search for other papers by Bernard Payrastre in
Google Scholar
PubMed Close
,
Coralie Fontaine Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France

Search for other papers by Coralie Fontaine in
Google Scholar
PubMed Close
,
Jean-François Arnal Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France

Search for other papers by Jean-François Arnal in
Google Scholar
PubMed Close
, and
Marie-Cécile Valera Inserm U1048 (I2MC), CHU de Toulouse and Université Toulouse III, I2MC, Toulouse, France
Faculté de Chirurgie Dentaire, Université de Toulouse III, Toulouse, France

Search for other papers by Marie-Cécile Valera in
Google Scholar
PubMed Close

.1161/CIRCULATIONAHA.106.642280 ) 17309934 7 Modena MG Sismondi P Mueck AO Kuttenn F Lignieres Bd Verhaeghe J Foidart JM Caufriez A Genazzani AR & TREAT . New evidence regarding hormone replacement therapies is urgently required transdermal

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0079
Volume/Issue:
Volume 8: Issue 6
Open access
Henrik H Thomsen Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Henrik H Thomsen in
Google Scholar
PubMed Close
,
Holger J Møller Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Holger J Møller in
Google Scholar
PubMed Close
,
Christian Trolle Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Christian Trolle in
Google Scholar
PubMed Close
,
Kristian A Groth Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Kristian A Groth in
Google Scholar
PubMed Close
,
Anne Skakkebæk Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed Close
,
Anders Bojesen Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Anders Bojesen in
Google Scholar
PubMed Close
,
Christian Høst Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Christian Høst in
Google Scholar
PubMed Close
, and
Claus H Gravholt Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed Close

controls. The design was a randomized crossover study. Both groups underwent a 2 month wash-out period from hormone replacement therapy (HRT) and oral contraceptive therapy (OCT) respectively. Subjects were examined at the end of each 2-month period. The

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-13-0067
Volume/Issue:
Volume 2: Issue 4
Open access